{"lastModified":"2026-08-20T22:00:44","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=18623","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DW8AEF","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/18623/body","rel":"body"}],"num":18623,"receiptDate":"2026-07-15","term":10,"title":"Interpelacja w sprawie dostępności terapii podskórnego leczenia chorych na hemofilię A niepowikłaną inhibitorem","answerDelayedDays":0,"from":["467"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2026-07-22"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDX5HEP/i18623-o1.pdf","lastModified":"2026-08-20T22:00:44","name":"i18623-o1.pdf"}],"from":"Podsekretarz stanu Katarzyna Kęcka","key":"DX5HEP","lastModified":"2026-08-20T22:00:44","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DX5HEP","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/18623/reply/DX5HEP/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2026-08-17"}],"sentDate":"2026-07-22","to":["minister zdrowia"]}